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ABSTRACT In recent years, both the molecular architecture and functional dynamics of nuclear pore complexes (NPCs)
have been revealed with increasing detail. These large, supramolecular assemblages of proteins form channels that span the
nuclear envelope of cells, acting as crucial regulators of nuclear import and export. From the cytoplasmic face of the nuclear
envelope, nuclear pore complexes exhibit an eightfold symmetric ring structure encompassing a central lumen. The lumen
often appears occupied by an additional structure alternatively referred to as the central granule, nuclear transport complex,
or nuclear plug. Previous studies have suggested that the central granule may play a role in mediating calcium-dependent
regulation of diffusion across the nuclear envelope for intermediate sized molecules (10–40 kDa). Using atomic force
microscopy to measure the surface topography of chemically fixed Xenopus laevis oocyte nuclear envelopes, we present
measurements of the relative position of the central granule within the NPC lumen under a variety of conditions known to
modify nuclear Ca2 stores. These measurements reveal a large, 9-nm displacement of the central granule toward the
cytoplasmic face of the nuclear envelope under calcium depleting conditions. Additionally, activation of nuclear inositol
triphosphate (IP3) receptors by the specific agonist, adenophostin A, results in a concentration-dependent displacement of
central granule position with an EC50 of1.2 nM. The displacement of the central granule within the NPC is observed on both
the cytoplasmic and nucleoplasmic faces of the nuclear envelope. The displacement is blocked upon treatment with
xestospongin C, a specific inhibitor of IP3 receptor activation. These results extend previous models of NPC conformational
dynamics linking central granule position to depletion of IP3 sensitive nuclear envelope calcium stores.
INTRODUCTION
Nuclear pore complexes (NPC) are enormous, 125 MDa
protein channels that span the nuclear envelope (NE), form-
ing conduits between nuclear and cytoplasmic spaces.
These macromolecular complexes may contain over 150
different protein subunits, forming eightfold rotationally
symmetric pores embedded within the nuclear envelope
(Akey, 1991; Akey and Radermacher, 1993; Fahrenkrog et
al., 2001; Forbes, 1992; Goldberg and Allen, 1993; Gold-
berg et al., 1997; Hinshaw, 1994; Kiseleva et al., 2000;
Pante and Aebi, 1996). NPCs govern both nuclear import of
endogenous modulators of gene expression as well as the
export of RNA to the cytoplasm (Bustamante et al., 1995;
Oberleithner, 1999; Oberleithner et al., 1996; Stolz et al.,
2000). In addition to roles in normal cellular physiology,
NPCs may also be targeted by viruses seeking to infiltrate
the nucleus (Kasamatsu and Nakanishi, 1998; Nakanishi et
al., 2001; Whittaker et al., 2000).
To date, much of what is known of the NPC architecture
comes from electron microscopy (EM) investigations and,
to a lesser extent, atomic force microscopy (AFM) studies.
The former have provided a detailed view of the static
structure of the NPC, whereas in vitro AFM has revealed a
more dynamic picture of NPC morphology (Danker et al.,
1997; Danker and Oberleithner, 2000; Fahrenkrog et al.,
2001; Perez-Terzic et al., 1996, 1999; Rakowska et al.,
1998; Schneider et al., 1995; Stoffler et al., 1999; Stolz et
al., 2000; Wang and Clapham, 1999). Generally, such stud-
ies find that the NPC is comprised of at least three major
structural elements: a cytoplasmic ring consisting of eight
similar subunits, a nuclear ring also exhibiting eight sub-
units, and a structure that consists of a spoke-like array
symmetrically occupying the NPC central lumen (Akey,
1995; Akey and Radermacher, 1993; Allen et al., 1997;
Goldberg and Allen, 1995; Goldberg et al., 1997; Hinshaw,
1994; Kiseleva et al., 2000; Pante and Aebi, 1993, 1995).
The cytoplasmic ring exhibits a nominal outer diameter of
120 nm, with subunits often found in EM studies deco-
rated with a series of filaments that extend into the cyto-
plasm. Subunits of the nuclear ring attach to a set of inter-
connected nucleoplasmic filaments collectively comprising
a structure called the nuclear basket (Fahrenkrog et al.,
2001; Pante and Aebi, 1996; Stoffler et al., 1999). The
central spoke complex lay between the cytoplasmic and
nucleoplasmic rings and possesses membrane-spanning do-
mains contacting both the NPC central lumen and the cis-
ternal space of the nuclear envelope. (Akey and Raderma-
cher, 1993; Goldberg and Allen, 1993, 1996; Hinshaw,
1994).
Complex processes regulate both passive and active
transport across the nuclear membrane. Active nuclear im-
port requires specific nuclear localization sequences on
transported molecules and often requires cytoplasmic fac-
tors that bind the cargo and facilitates their transport
through the NPC channel. In contrast, passive transport
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through the NPC does not require nuclear localization se-
quences on the transporting species or the help of soluble
factors. The size of passively transported molecules ranges
from that of freely permeable ions up to species of 40
kDa. Whereas the passive transport of molecules smaller
than 10 kDa across the nuclear envelope is driven by con-
centration gradients alone, evidence suggests that diffusion
of species in the 10 to 40 kDa range can be regulated by
intracellular calcium levels (Allen et al., 2000; Lee et al.,
1998; Stehno-Bittel et al., 1995b, 1996). Specific depletion
of nuclear envelope calcium stores by inositol triphosphate
(IP3)-sensitive ion channels has been shown by several
groups to block the passive transport of these molecules into
the nucleus (Lee et al., 1998; Stehno-Bittel et al., 1995a,b,
1996).
Interestingly, high-resolution electron microscopy and
AFM studies often observe the presence of a mass in the
central lumen of the NPC after depletion of the nuclear
envelope calcium stores. This mass is alternately referred to
as the “central granule,” “central plug,” or “transporter
complex”(Goldberg and Allen, 1993; Perez-Terzic et al.,
1996). EM studies suggest that the transporter complex may
span the entire central lumen of the NPC, comprising a
centrally tapered cylinder with globular domains at either
end (Allen et al., 1996, 1997; Gant et al., 1998; Goldberg et
al., 1992; Kiseleva et al., 2000; Rutherford et al., 1997). As
the presence of the central granule was correlated with
depletion of nuclear envelope calcium, it was suggested that
changes in nuclear envelope permeability might result from
changes in the position of central granule (Lee et al., 1998;
Perez-Terzic et al., 1996, 1997; Wang and Clapham, 1999).
Others, however, have questioned the physiological signif-
icance of the central granule (Fahrenkrog et al., 2001;
Stoffler et al., 1999; Stolz et al., 2000). Some believe that
the central granule may simply represent cargo caught in
transit or structures such as the nuclear basket collapsing
into the central lumen of the NPC (Fahrenkrog et al., 2001;
Stoffler et al., 1999; Stolz et al., 2000).
Two groups have recently reported conflicting results for
AFM measurements on unfixed nuclear envelopes under
buffered conditions (Stoffler et al., 1999; Stolz et al., 2000;
Wang and Clapham, 1999). Using a scheme that classified
NPCs as either “open” or “closed,” Wang and Clapham
(1999) found that 80% of NPCs appeared “plugged” under
calcium depleting conditions when viewed from the cyto-
plasmic side of the envelope. A two-state model of NPC
conformation was proposed in which the central granule
could adopt a “plugged” or “unplugged” state depending on
cisternal calcium levels (Wang and Clapham, 1999). Similar
AFM measurements on unfixed tissues carried out by Aebi
and coworkers, however, found no evidence for calcium-
dependent conformational changes on the cytoplasmic face
of the NPC. Instead, they found that the morphology of the
NPC on the nuclear face of the envelope was changed by
altering external calcium concentrations. Based on their
observations, Aebi and coworkers proposed an alternate
model for calcium-mediated conformational changes in
which changes in the nuclear basket assembly might modify
passive diffusion through the NPC and explain the appear-
ance of the central granule (Fahrenkrog et al., 2001; Stoffler
et al., 1999; Stolz et al., 2000).
In an attempt to unify and extend these earlier studies, we
report extensive measurements of the central granule posi-
tion as a function of treatments known to alter nuclear
calcium concentrations (Stoffler et al., 1999; Stolz et al.,
2000; Wang and Clapham, 1999). These treatments in-
cluded variations in calcium concentrations of bathing so-
lutions, addition of ATP, and activation of nuclear IP3
receptors with IP3. Moreover, we examined the location of
the central granule with varying degrees of IP3 receptor
stimulation produced by the IP3 receptor agonist, adeno-
phostin A (Mak et al., 2001; Takahashi et al., 1994). Treat-
ments found to decrease nuclear cisternal calcium resulted
in an apparent shift in the position of the central granule of
NPC populations 9 nm toward the rim of the NPC cyto-
plasmic ring. Pharmacological activation of IP3 receptors by
adenophostin A, revealed the magnitude of the shift to be
concentration dependent, exhibiting an EC50 of 1.2 nM.
The shift in central granule position after IP3 receptor acti-
vation was blocked by xestospongin C, a specific inhibitor
of IP3 receptor activation (De Smet et al., 1999; Gafni et al.,
1997). In addition, activation of IP3 receptors resulted in a
decrease in the depth of NPCs (10 nm) measured from the
nuclear surface of the envelope. These results are consistent
with the idea of a calcium sensitive conformational change
in the NPC that alters its permeability. The role of specific
NPC components in calcium sensing are discussed.
MATERIALS AND METHODS
Preparation of nuclear envelopes
Oocytes were removed from adult female Xenopus laevis (Xenopus Ex-
press, Homosassa, FL) following the procedure outlined by Marcus-Sekura
(Marcus-Sekura and Hitchcock, 1987). Once removed, oocytes were
placed in Barth’s solution containing: 10 mM HEPES, 88 mM NaCl, 1 mM
KCl, 0.82 mMMgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, and 200 units
penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO), adjusted to a pH
of 7.4. If not used immediately, oocytes were stored at 4°C for no longer
than 1 day.
Nuclei were removed from oocytes using precision forceps and cleared
of cytoplasmic debris by several cycles of gently drawing the nuclei into
and out of the tip of a Pasteur pipette. Once isolated, nuclei were trans-
ferred to a mock intracellular buffer solution containing either: 140 mM
KCl, 2.99 mM MgCl2, 10 mM HEPES at a pH of 7.2 (no added Ca
2) or
90 mM KCl, 10 mM NaCl, 2 mMMgCl2, 1.1 mM EGTA, 0.75 mM CaCl2,
10mM HEPES at a pH of 7.32 (free Ca2 200 nM) depending on
treatment conditions (see Results). After a minimum of 10-min incubation,
nuclei were transferred to 5-mL plastic petri dishes containing 4 mL of the
specific treatment solution. Nuclei were maintained in treatment solutions
for 10 min. Adenophostin A, D-myo inositol 1,4,5-triphosphate, and xes-
tospongin C (Calbiochem, San Diego, CA) were all used without further
purification.
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After the treatment period, intact nuclei were transferred to 12-mm glass
coverslips and immersed in 5% paraformaldehyde prepared in an appro-
priate mock intracellular solution. The intact nuclei were incubated for 15
min after which they were gently pierced with two fire-polished glass
micropipettes. Chromatin was teased out of the nuclei, and the membranes
were carefully flattened onto the coverslip surface. Flattened membranes
were rinsed twice in distilled water and air-dried. All treatment and fixation
procedures were performed at room temperature (23°C).
Atomic force microscopy
Atomic force microscopy measurements were performed using a Digital
Instruments (Santa Barbara, CA) Nanoscope IIIa control station and mul-
timode head. Sharpened silicon nitride AFM tips (Ultra-sharp, Microm-
asch, Tallinn, Estonia) with a nominal spring constant of 0.60 N/m were
used in contact mode for all measurements. All AFM images used for
analysis were collected on 1.5 m  1.5 m sample areas at 512  512
pixel resolution.
To precisely extract the depth of the central granule within the NPC
from the AFM data, topography images were analyzed using custom
written macros running on a modified version of NIH Image (v1.62). For
each NPC, 24 profile plots passing through the NPC center were collected
at 7.5° intervals. Each set of 24 profile plots then was averaged together to
produce a representative cross-section of each NPC. From this, the position
of the central granule was calculated as the difference in height between the
outer rim of the NPC and the top of the central granule.
RESULTS
Fig. 1 displays representative AFM images of the cytoplas-
mic (Fig. 1 a) and nucleoplasmic (Fig. 1 b) sides of the
nuclear envelope. Great care was taken to insure that the
appropriate side of the NE was imaged for a particular set of
measurements because such ambiguities might be one
source of the inconsistencies found in the literature. Nuclear
membranes were carefully oriented on the surface manually
and further checked for proper orientation using the AFM to
identify distinct morphological markers. For instance, the
nuclear face of the NE exhibits fibrous structures that
stretch across the surface of the membranes (Fig. 1 b).
These structures extend for tens of micrometers and are
identified as lamin fibers in previous AFM and scanning
electron microscope measurements (Goldberg and Allen,
1992, 1995, 1996; Schneider et al., 1995).
The fidelity maintained in the membrane structure was
evidenced by a density of NPCs in the NE that is consistent
with densities measured in other laboratories working with
unfixed, native NEs. This suggests that the membrane prep-
aration did not significantly alter the gross features of mem-
brane morphology or modify the NPC distributions within
the NE. The observation of small lamin fibers on the nuclear
face of the membrane indicates that finer details of the NE
were also preserved in the fixing process.
For these measurements, the pore depth was defined as
the distance from the rim of the NPC to the top of the central
granule. Large negative numbers reflected pores in which
the granule was maximally recessed below the cytoplasmic
ring of the NPC (“open”). An outward displacement of the
central granule was reflected in pore depth measurements
that evolved toward less negative or positive values
(“closed”).
Fig. 2 displays population histograms of the central gran-
ule position after the treatments indicated in the inset of the
plots. The four histograms displayed in Fig. 2, A through D,
result from measurements on nuclei subjected to various
levels of ambient calcium. After preincubation, nuclei were
incubated in modified mock intracellular solutions contain-
ing either 2 M Ca2  5 mM ATP, 2 M Ca2, 200 nM
FIGURE 1 AFM images of the cytoplasmic (A) and nucleoplasmic (B) sides of the nuclear envelope. The 1.5 m  1.5 m areas reveal the dense
packing of NPCs in the membrane. (A) On the cytoplasmic side, many of the NPCs appear occluded by a mass known as the central granule (arrows). (B)
On the nucleoplasmic side, the small filament lamin structures are clearly visible.
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Ca2, or the preincubation (nominally Ca2 free) mock
intracellular solution for 10 min and then fixed and imaged.
After treatment with 2 M Ca2  5mM ATP (Fig. 2 A),
the NPCs appeared in the most open configuration with the
largest negative pore depth indicating that the central gran-
ule was recessed furthest from the rim of the NPC. The
distributions were seen to gradually shift toward a more
closed state (less recessed central granule) as the amount of
ambient calcium was reduced.
The cisternal calcium can also be modified by specifi-
cally triggering the release of calcium through IP3 receptors
located in the NE. Previous reports on the effect of ambient
calcium levels on IP3 receptor activation concluded that IP3
receptors are maximally active at ambient calcium concen-
trations of 200 nM. (Stehno-Bittel et al., 1995a) To probe
the effects of depleting nuclear cisternal calcium stores by
IP3 receptor activation, intact nuclei were preincubated in
mock intracellular buffer containing 200 nM Ca2 for 10
min. After incubation, nuclei were transferred to treatment
solutions containing 1 M IP3 (with 200 nM Ca
2) for
another 10 min. AFM measurements on these NEs resulted
in the depth histogram shown in Fig. 2 E.
IP3 receptors were also stimulated by the addition of
adenophostin A. Unlike IP3, adenophostin A is more stable
and less sensitive to functional regulation by enzymes con-
trolling phosphatidyl inositol metabolism. Additionally, ad-
enophostin A has been shown to exhibit a much greater
potency in stimulating IP3 receptor activation (Hotoda et al.,
1999; Murphy et al., 1997). Fig. 2 F displays the central
granule location histogram after incubation with 2 nM ad-
enophostin A. The NPCs appear predominantly in the
“closed” state with the central granule located near the NPC
rim.
In general, the histograms displayed in Fig. 2 are struc-
tureless and reveal that the central granule can be positioned
in a number of conformational states. This is evidenced by
shifting distributions that move toward the “closed” state
upon depletion of cisternal calcium. This is also seen in Fig.
3 in which the mean plug location and standard deviation
calculated from the histograms shown in Fig. 2 are plotted.
The bar graphs show the transition of central granule posi-
tions from the most “open” state at high calcium loading to
the most “closed” state upon activation of the IP3 receptors
with either IP3 or adenophostin A. The treatments and the
respective measured pore depths are as follows: 2 M Ca2
 5 mM ATP, average pore depth  8.0  0.2 nm (n 
647, in two nuclei); 2 M Ca2, average pore depth 
6.8  0.1 nm (n  1014, in four nuclei); 200 nM Ca2,
FIGURE 2 Population histograms of central granule location with the
various calcium modifying treatments shown in the panel insets. Large
negative numbers signify a recessed central granule position, a state iden-
tified as being “open.” As seen in the histograms, treatments known to
decrease the cisternal calcium levels shift the location of the central granule
toward less negative numbers. These populations are identified with NPCs
in a more “closed” state with the central granule shifted toward the
cytoplasmic side of the NE.
FIGURE 3 Average central granule location calculated from the popu-
lation histograms shown in Fig. 2. The average pore depths after the
various chemical treatments are: 2 M Ca2  5 mM ATP, average pore
depth of 8.0  0.2 nm (n  647, in two nuclei); 2 M Ca2, average pore
depth of 6.8  0.1 nm (n  1014, in four nuclei); 200 nM Ca2, average
pore depth of 5.3 0.1 nm (n 429, in one nucleus); nominally Ca2 free
mock intracellular buffer, average pore depth of 4.4  0.2 nm (n  202,
in one nucleus); 1 M IP3, average pore depth of 2.2  0.1 nm (n  1256,
in three nuclei); 2 nM adenophostin A, average pore depth of 1.9 0.1 nm
(n  519, in one nucleus).
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average pore depth  5.3  0.1 nm (n  429, in one
nucleus); Ca2 free mock intracellular buffer, average pore
depth 4.4 0.2 nm (n 202, in one nucleus); 1 M IP3,
average pore depth  2.2  0.1 nm (n  1256, in three
nuclei); and 2 nM adenophostin A, average pore depth 
1.9  0.1 nm (n  519, in one nucleus).
The specific regulation of NPC conformation by IP3
sensitive calcium stores was also explored. Using a specific
pharmacological agonist of IP3 receptors, adenophostin A, a
dose-response relationship between IP3 receptor activation
and NPC conformation was examined. Fig. 4 plots the
results of measured pore depths with increasing concentra-
tion of adenophostin A. It is important to note that in these
experiments there was no difference in ambient calcium
concentrations between treatments. Adenophostin A con-
centration was the only parameter varied. The dose-re-
sponse curve reveals an EC50 of 1.2 nM adenophostin A.
As shown in Fig. 5, the effects of adenophostin A activation
of IP3 receptors are blocked upon addition of 20 M xes-
tospongin C, a specific inhibitor of IP3 receptor activation.
Finally, preliminary measurements on the nucleoplasmic
side of the NE also revealed changes in NPC conformation
upon activation of the IP3 receptors. Fig. 6 compares the
conformational changes observed on both the cytoplasmic
and nucleoplasmic sides of the NPC after low and high
doses of adenophostin A. The reported cytoplasmic and
nucleoplasmic channel depths are measured relative to the
cytoplasmic or nucleoplasmic rim of the NPC, respectively.
After treatments with 80 pM adenophostin A, the pore
depths measured from the cytoplasmic and nucleoplasmic
faces yielded depths of 7.0  0.1 nm, (n  550, one
nucleus) and 10.0  0.4 nm, (n  270, one nucleus),
respectively. After 10 nM adenophostin A treatments, pore
depths measured from the cytoplasmic and nucleoplasmic
faces, respectively, yielded values of 2.6  0.1 nm (n 
547, one nucleus) and 3.3 0.1 nm (n 509, one nucleus).
Interestingly, both sides of the NPC appear “unblocked” at
FIGURE 4 Adenophostin A induced displacement of central granule
position. The average pore depths after adenophostin A treatment are: no
added adenophostin A and 200 nM Ca2, average pore depth of 5.3 0.1
nm (n 429, in one nucleus); 0.08 nM adenophostin A, average pore depth
of 7.0  0.1 nm (n  550, in one nucleus); 0.4 nM adenophostin A,
average pore depth of 6.8  0.4 nm (n  174, in one nucleus); 1.2 nM
adenophostin A, average pore depth of 5.1  0.1 nm (n  522, in one
nucleus); 2 nM adenophostin A, average pore depth of 1.9  0.1 nm (n 
519, in one nucleus); 10 nM adenophostin A, average pore depth of 2.6 
0.1 nm (n  547, in one nucleus); 250 nM adenophostin A, average pore
depth of 3.0  0.1 nm (n  452, in one nucleus). The sigmoidal shaped
dose-response curve reveals an EC50 of 1.2 nM, which is in close agree-
ment with bulk measurements of adenophostin A activity.
FIGURE 5 Comparison of average NPC pore depths after treatment with
xestospongin C, a specific inhibitor of IP3 receptor activation. Without
xestospongin C, treatment of nuclei with 10 nM adenophostin A resulted in
an average pore depth of 2.6  0.1 nm (n  547, in one nucleus). The
combination of 10 nM adenophostin A and 20 M xestospongin C,
however, resulted in an average pore depth of 8.7  0.2 nm (n  470, in
one nucleus). The significant difference in central granule location with
xestospongin C treatment, suggest a specific functional link between IP3
receptor activation and NPC conformational state (p  0.01).
FIGURE 6 Comparison of pore depths taken on the cytoplasmic and
nucleoplasmic NE surfaces for two different dosing levels of adenophostin
A. The reported depths are taken relative to the respective rim of the NPC.
At dosing levels of 0.08 nM adenophostin A, NPCs on the cytoplasmic side
had an average pore depth of 7.0  0.1 nm (n  550, in one nucleus) and
10.5  0.4 nm (n  270, for one nucleus) for the nucleoplasmic face. At
the higher dosing level of 10 nM adenophostin A, NPCs on the cytoplasmic
side had an average depth of 2.6  0.1 nm (n  547, in one nucleus),
whereas those on the nucleoplasmic side had an average depth of 3.3 0.1
nm (n  509, for one nucleus). Interestingly, upon depletion of cisternal
calcium, both sides appear more occluded.
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low adenophostin A concentrations and both appear
“blocked” at high concentrations.
DISCUSSION
The role of calcium in modifying the permeability of the
NPC continues to be a subject of some debate in the liter-
ature (Greber and Gerace, 1995; Santella and Carafoli,
1997, 1999). Early measurements suggested that calcium
induced conformational changes in the NPC modulated
permeability and that these changes were predominantly
associated with the position of the central granule within the
NPC (Perez-Terzic et al., 1996, 1997; Wang and Clapham,
1999). Recently, however, conflicting observations have
questioned the validity of this mechanism (Fahrenkrog et
al., 2001; Stoffler et al., 1999; Stolz et al., 2000). Those
measurements have cast doubt on the role of the central
granule in NPC permeability and its positional sensitivity to
cisternal calcium levels. Often, however, the calcium treat-
ments and conditions used in the various laboratories are not
uniform, which makes comparisons problematic. One goal
of the measurements reported here was to unify previous
work by studying NPC conformation over a wide range of
calcium modifying conditions.
The findings reported here unambiguously reveal a sen-
sitivity of the central granule position to cisternal calcium
levels. A systematic shift in the plug location toward the
cytoplasmic face of the NPC was observed as the cisternal
calcium levels were decreased. Moreover, specific activa-
tion of the IP3 receptors in the NE with either IP3 or
adenophostin A resulted in a large shift in the central
granule position toward the cytoplasmic face of the NPC.
These receptors are known to release the cisternal calcium
stores of the NE after activation (Lee et al., 1998; Stehno-
Bittel et al., 1995a, 1996). This further supports a correla-
tion between NPC conformational regulation and NE cal-
cium stores.
It has been shown previously that 2 M Ca2 treatments
combined with 5 mM ATP results in calcium uptake into
NEs through the activation of membrane calcium transport-
ers powered by ATP (Perez-Terzic et al., 1996; Stehno-
Bittel et al., 1995a,b) As shown in Fig. 3, we find that this
treatment results in the greatest number of pores in which
the central granule is maximally recessed within the NPC
complex. In the absence of ATP, treatments with 2 M
calcium alone resulted in populations exhibiting signifi-
cantly less recessed positions of the central granule (p 
0.01). As the ambient calcium levels are further reduced, a
transition in central granule position toward the cytoplasmic
face of the NPC was observed (Figs. 2 and 3). These results
reveal a sensitivity of the central granule location to the
cisternal calcium levels and argue that the NPC can adopt a
number of conformational states.
Studies have found that IP3 receptors are abundant in the
NE and are responsible for the release of the cisternal
calcium stores (Mak and Foskett, 1994, 1997; Stehno-Bittel
et al., 1995a) Moreover, stimulated depletion of nuclear
calcium stores with IP3 inhibits the passive transport of 10
kDa dextrans across the NEs of isolated, intact Xenopus
nuclei (Greber and Gerace, 1995; Stehno-Bittel et al.,
1995a, 1996).
This suggests a functional link between IP3 receptor
activation and NPC permeability. To further probe this link,
NPC conformation state was characterized after treatments
with IP3, the physiological agonist of the receptor, and the
more potent analogue adenophostin A. As shown in Figs. 2
and 3, both treatments resulted in the largest shift in the
central granule location within the NPC. To establish phar-
macological specificity, dose-response curves were mea-
sured after adenophostin A treatments.
Adenophostin A was chosen for the dose-response stud-
ies because, unlike IP3, adenophostin A is less sensitive to
functional regulation by enzymes controlling phosphatidyl
inositol metabolism and is more potent in stimulating the
release of intracellular calcium stores (Hotoda et al., 1999;
Murphy et al., 1997). Fig. 4 shows the central granule
location as a function of adenophostin A concentration. We
find that increasing concentrations of adenophostin A does
appear to drive a dose-dependent movement of the central
granule toward the cytoplasmic face of the NPC. The sig-
moidal shaped curve reveals EC50 of 1.2 nM, which is
consistent with bulk studies of adenophostin A activity
(Adkins et al., 2000). Moreover, as shown in Fig. 5, treat-
ments with xestospongin C blocked the action of adeno-
phostin A. These observations argue for the pharmacological
specificity of IP3 receptor activation and its role in influencing
the location of the central granule within the NPC.
Our data suggest a strong correlation exists between
agonist-induced depletion of nuclear calcium stores and
central granule position within the NPC cytoplasmic lumen.
It appears likely, therefore, that the conformational changes
observed by Wang and Clapham are indeed a consequence
of IP3 receptor-mediated depletion of NE calcium stores.
Consistent with this, changes in the position of the central
granule are also likely to be linked to mechanisms through
which NPC permeability is regulated, as originally pro-
posed (Lee et al., 1998; Perez-Terzic et al., 1996, 1997;
Wang and Clapham, 1999). Our data, however, does not
support a two-state model for central granule location. In-
stead, we find a shift in central granule location in response
to calcium modifying treatments that reflects a distribution
of available conformational states.
Preliminary measurements of NPC conformation on the
nucleoplasmic side of the NE are compared with similar mea-
surements made on the cytoplasmic side in Fig. 6. As seen in
Fig. 6, large conformational changes in the NPC are observed
on both sides of the NE after treatment with 10 nM adeno-
phostin A. Interestingly, both sides of the NPC reveal a de-
crease in pore depth with release of NE cisternal calcium
stores. This suggests a more complex mechanism of confor-
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mational change than a simple unidirectional shifting of central
granule location in response to cisternal calcium levels.
The large number of single pore measurements reported
here reveal a shift in the central granule location as a
function of treatments known to modify cisternal calcium
levels. Moreover, the dose-response measurements shown
in Fig. 4 suggest a pharmacological link between IP3 recep-
tor activity and the location of the central granule within the
NPC. The identity of the central granule, however, remains
unclear. Because AFM measurements, for the most part,
reveal only topographical changes it is not easy to distin-
guish whether the central granule is an integral protein
constituent of the NPC or simply cargo caught in transit.
The dose-response measurements, however, suggest that at
least some of the movement results from an integral com-
ponent of the NPC structure. Moreover, the observation of
a decrease in pore depth from both sides of the NPC with
adenophostin A treatment suggest that the shifts are not
entirely due to cargo. While cargo may be present, it is not
likely that cargo alone would lead to the correlated varia-
tions in pore depth observed on both sides of the NE.
It should also be mentioned that if cargo is present, it
might lead to variations in the pore depth measurements.
This would tend to obscure structure otherwise present in
the measured histograms. In other words, the histograms
shown in Fig. 2 do not in themselves support a two-state
model for central granule location. However, if these mea-
surements represent a combination of both height informa-
tion from central granule movement and that of cargo, then
there may be specific substates in the central granule loca-
tion that are not visible in the measured histograms.
Although the exact calcium depletion sensor in the NPC
responsible for the central granule motion has not been
identified, a likely candidate appears to be the Ca2 binding
protein gp210. This protein is present in each subunit of the
eightfold symmetric NPC and contains Ca2 binding mo-
tifs. Moreover, the role of gp210 in the passive permeability
of the NPC has been implicated through studies in which
antibodies raised to its lumenal domain have been found to
inhibit passive diffusion. In addition, gp210 seems well
suited structurally to act as a calcium sensor. It is a trans-
membrane protein with domains extending both into the
cisternal region of the NE, where the calcium stores are
located, and into the lumen of the NPC, where the central
granule is observed (Greber and Gerace, 1992; Meier et al.,
1995). Presumably, the domains found in the NE cisterna
would act as the calcium sensor, and the domains extending
into the NPC lumen would act as the effector. Measure-
ments are currently underway to explore the role of gp210
in modulating NPC permeability.
CONCLUSIONS
The measurements reported here clearly show a correlation
between nuclear cisternal calcium levels and conformation
changes taking place within the NPC. Changes in the am-
bient calcium levels of the bathing solution as well as more
specific modifiers of NE calcium are shown to result in
changes in the position of the central granule. In general,
treatments that lower the NE calcium levels result in a shift
of the central granule toward the cytoplasmic side of the
NPC. A similar shift toward the nucleoplasmic face of the
NPC is also observed upon calcium depletion. In addition, a
large change in the central granule location is observed after
activation of IP3 receptors with either IP3 or the more potent
and stable agonist adenophostin A. Dose-response curves of
central granule location with adenophostin A treatments
reveals a sigmoidal shaped curve with an EC50 of1.2 nM.
This response is blocked upon addition of xestospongin C,
a specific inhibitor of IP3 activity. Together these observa-
tions illustrate the pharmacological specificity of the con-
formational response and argue for the physiological cou-
pling of IP3 receptor activity and NPC permeability.
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